Genetics of Lipoprotein(a): Cardiovascular Disease and Future Therapy Anne LangstedBørge G. Nordestgaard Genetics and Genomics (A. Marian, Section Editor) 20 June 2021 Article: 46
Novel RNAi-Based Therapies for Atherosclerosis Anna-Kaisa RuotsalainenPetri MäkinenSeppo Ylä-Herttuala Genetics and Genomics (A. Marian, Section Editor) Open access 19 June 2021 Article: 45
Is There a Role of Coronary CTA in Primary Prevention? Current State and Future Directions Martin Bødtker MortensenMichael J. Blaha Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) 19 June 2021 Article: 44
Hypertension in Women Across the Lifespan Lama GhaziNatalie A. Bello Women and Ischemic Heart Disease (J.M. Peña and F. Lin, Section Editors) 19 June 2021 Article: 43
Special Considerations for Lipid-Lowering Therapy in Women Reflecting Recent Randomized Trials Anandita AgarwalaAnne Goldberg Women and Ischemic Heart Disease (J.M. Peña and F. Lin, Section Editors) 19 June 2021 Article: 42
Lipoprotein (a): Recent Updates on a Unique Lipoprotein Anum SaeedSina KinoushSalim S. Virani Coronary Heart Disease (S. Virani and S. Naderi, Section Editors) 19 June 2021 Article: 41
The Role of RNA-Targeted Therapeutics to Reduce ASCVD Risk: What Have We Learned Recently? Marcio H. MinameViviane Z. RochaRaul D. Santos Coronary Heart Disease (S. Virani and S. Naderi, Section Editors) 19 June 2021 Article: 40
The Genetic Basis of Hypertriglyceridemia Germán D. CarrasquillaMalene Revsbech ChristiansenTuomas O. Kilpeläinen Genetics and Genomics (A. Marian, Section Editor) Open access 19 June 2021 Article: 39